Eagle Pharmaceuticals, Inc. Deferred Tax Assets, Other
Eagle Pharmaceuticals, Inc. had Deferred Tax Assets, Other of $3.66 million as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2023-03-23
- 2022-12-31: Deferred Tax Assets, Other $3.66M.
- 2021-12-31: Deferred Tax Assets, Other $1.49M.
- 2020-12-31: Deferred Tax Assets, Other $1.22M; Deferred Tax Assets, Other as first filed $737.00K.
- 2019-12-31: Deferred Tax Assets, Other $1.02M.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2022-12-31 | $3.66M 10-K · filed 2023-03-23 | |
| 2021-12-31 | $1.49M 10-K · filed 2023-03-23 | |
| 2020-12-31 | $1.22M 10-K · filed 2022-03-08 | $737.00K 10-K · filed 2021-03-05 |
| 2019-12-31 | $1.02M 10-K · filed 2021-03-05 | |
| 2018-12-31 | $64.00K 10-K · filed 2020-03-02 | |
| 2017-12-31 | $641.00K 10-K · filed 2019-02-28 | $1.41M 10-K · filed 2018-02-26 |
| 2016-12-31 | $285.00K 10-K · filed 2018-02-26 | |
| 2015-12-31 | $254.00K 10-K · filed 2017-03-15 | $2.00K 10-K · filed 2016-02-29 |
| 2014-12-31 | $11.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $2.00K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $2.00K 10-K · filed 2016-02-29 |